Description: NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics. The Company is engaged in the development of intellectual property. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients; Glucosense, a provider of a non-invasive glucose monitoring wearable device; Vortex Biosciences, which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing; Glycotest, which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis, and ProAxsis, which is engaged in respiratory disease diagnosis and treatment monitoring.
Home Page: www.netscientific.net
NSCI Technical Analysis
20 St. Andrew Street
London,
EC4A 3AG
United Kingdom
Phone:
44 20 3514 1800
Officers
| Name | Title |
|---|---|
| Dr. Ilian Petkov Iliev Ph.D. | CEO & Exec. Director |
| Mr. Stephen D. Crowe | CFO & Sec. |
| Ms. Vyara Stoycheva | Investment Mang. |
| Mr. Oliver ?aban | Head of Bus. Devel. |
| Mr. Nick Salisbury | Head of Private Clients |
| Dr. Frank K. Bedu-Addo Ph.D. | Chief Exec. Officer of PDS Biotechnology |
| Dr. David Ribeiro | Chief Exec. Officer of Proaxsis |
| Mr. Kevin Dean | Venture Partner |
| Mr. Harry Miller | Investment Associate |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9348 |
| Price-to-Sales TTM: | 12.934 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 25 |